Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems

Brain Research

Volumn 708, Issue 1-2, 1996, Pages 38-44

  Healy, Daniel J ^a,b   Meador Woodruff, James H ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cortex; Dizocilpine; Glutamate; In situ hybridization; Midbrain; N Methyl D aspartate (NMDA); Striatum

Indexed keywords

DIZOCILPINE; DOPAMINE RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030023750     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01241-9     Document Type: Article

References (53)

1. Areneda, R. and Bustos, G., Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra, J. Neurochem., 52 (1989) 962-970.
2. Arias-Montano, J.A., Martinez-Fong, D. and Aceves, J., Glutamate stimulation of tyrosine hydroxylase is mediated by NMDA receptors in the rat striatum, Brain Res., 569 (1992) 317-322.
3. Bowyer, J.F., Spuhler, K.P. and Weiner, N., Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes, J. Pharmacol. Exp. Ther., 229 (1984) 671-680.
4. Bowyer, J.F., Newport, G.D., Lipe, G.W. and Frame, L.T., A further evaluation of the effects of K+ depolarization on glutamate-evoked [3H]dopamine release from striatal slices, J. Pharmacol. Exp. Ther., 261 (1992) 72-80.
5. Cai, N.S., Kiss, B. and Erdo, S.L., Heterogeneity of N-methyl-D-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices, J. Neurochem., 57 (1991) 2148-2151.
6. Carboni, E., Imperato, A., Perezzani, L. and Di Chiara, G., Amphetamine, cocaine, phencyclidine and nomiphensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats, Neuroscience, 28 (1989) 653-661.
7. Carlsson, M. and Carlsson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease, Trends Neurosci., 13 (1990) 272-276.
8. Carter C.J., L'Heureux, R. and Scatton, B., Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study, J. Neurochem., 51 (1988) 462-468.
9. Cepeda, C., Buchwald, N.A. and Levine, M.S., Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated, Proc. Natl. Acad. Sci. USA, 90 (1993) 9576-9580.
10. Chowdhury, M. and Fillenz, M., Presynaptic adenosine A2 and N-methyl-D-aspartate receptors regulate dopamine synthesis in rat striatal synaptosomes, J. Neurochem., 56 (1991) 1783-1788.
11. Clow, D.W. and Jhamandas, K., Characterization of L-glutamate action on the release of endogenous dopamine from rat caudate-putamen, J. Pharmacol. Exp. Ther., 248 (1989) 722-728.
12. DeBelleroche, J.S. and Bradford, H.F., Presynaptic control of the synthesis and release of dopamine form striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine and glutamate, J. Neurochem., 35 (1980) 1227-1234.
13. Desce, J.M., Godeheu, G., Galli, T., Artaud, F., Cheramy, A. and Glowinski, J., Presynaptic facilitation of dopamine release through D,L-α-amino-3-hydroxy-5-methyl-4-isoxazole proprionate receptors on synaptosomes from the rat striatum, J. Pharmacol. Exp. Ther., 259 (1991) 692-698.
14. Desce, J.M., Godeheu, G., Galli, T., Glowinski, J. and Cheramy, A., Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes, Brain Res., 640 (1994) 205-214.
15. Giorguieff, M., Kernel, M.L. and Glowinski, J., Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices, Neurosci. Lett., 6 (1977) 73-77.
16. Grace, A.A., The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia, J. Neural Transm., Suppl., 36 (1992) 91-131.
17. Guan, X.-M. and McBride, W.J., Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release, Brain Research Bull., 23 (1989) 541-547.
18. Hansbauer, I., Wink, D., Osawa, Y., Edelman, G.M. and Gally, J.A., Role of nitric oxide in NMDA-evoked release of 3H-dopamine from striatal slices, NeuroReport, 3 (1992) 409-412.
19. Imperato, A., Honore, T. and Jensen, L.H., Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats, Brain Res., 530 (1990) 223-228.
20. Jhamandas, K. and Marien, M., Glutamate-evoked release of endogenous brain dopamine: Inhibition by an excitatory amino acid antagonist and an enkephalin analogue, Br. J. Pharmacol., 90 (1987) 641-650.
21. Jones, C.A., Zempleni, E., Davis, B. and Reynolds, G.P., Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro, Eur. J. Pharmacol., 242 (1993) 183-187.
22. Kalivas, P.W., Duffy, P. and Barrow, J., Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes, J. Pharmacol Exp. Ther. , 251 (1989) 378-387.
23. Kashihara, K., Hamamura, T., Okumura, K. and Otsuki, S., Effect of MK-801 on endogenous dopamine release in vivo, Brain Research, 528 (1990) 80-82.
24. Keefe, K.A., Zigmond, M.J. and Abercrombie, E.D., Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input, Neuroscience, 47 (1992) 325-332.
25. Kiss, J.P., Toth, E., Lajtha, A. and Vizi, E.S., NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study, Brain Res., 641 (1994) 145-148.
26. Kobayashi, K. and Inoue, O., An increase in the in vivo binding of [3H]SCH-23390 induced by MK-801 in the mouse striatum, Neuropharmacology, 32 (1993) 341-348.
27. Krebs, M.O., Desce, J.M., Kernel, M.L., Gauchy, C., Godeheu, G., Cheramy, A. and Glowinski, J., Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic terminals, J. Neurochem., 56 (1991) 81-85.
28. Krebs, M.O., Trovero, F., Desban, M., Gauchy, C., Glowinski, J. and Kernel, M.L., Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome-and matrix-enriched areas of the rat striatum, J. Neurosci., 11 (1991) 1256-1262.
29. Liljequist, S., Ossowska, K., Grabowski-Anden, M. and Anden, N.-E., Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice, Eur. J. Pharmacol., 195 (1991) 55-61.
30. Lillrank, S.M., O'Connor, W.T., Saransaari, P. and Ungerstedt, U., In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized rats, Acta Physiol. Scand., 150 (1994) 109-115.
31. Lonart, G. and Zigmond, M.J., High glutamate concentrations evoke Ca++-independent dopamine release from striatal slices: a possible role of reverse dopamine transport, J. Pharmacol. Exp. Ther., 256 (1991) 1132-1138.
32. Mansour, A., Meador-Woodruff, J.H., Zhou, Q.-Y., Civelli, O., Akil, H. and Watson, S.J., A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques, Neuroscience, 45 (1991) 359-371.
33. Meador-Woodruff, J.H., Neuroanatomy of dopamine receptor gene expression: potential substrates for neuropsychiatrie illness, Clin. Neuropharmacol., 18 (1995) S14-S24.
34. 2 dopamine receptor mRNAs in rat brain, Neuropsychopharmacology, 5 (1991) 231-242.
35. Meador-Woodruff, J.H., Mansour, A., Grandy, D.K., Damask, S., Civelli, O. and Watson, S.J., Distribution of D5 dopamine receptor mRNA in rat brain, Neurosci. Lett., 145 (1992) 209-212.
36. Meador-Woodruff, J.H., Damask, S. and Watson, S.J., Differential expression of autoreceptors in ascending dopamine systems of human brain, Proc. Natl. Acad. Sci. USA, 91 (1994) 8297-8301.
37. Moghaddam, B., Gruen, R.J., Roth, R.H., Bunney, B.S. and Adams, R.N., Effect of L-glutamate on the release of straital dopamine: in vivo dialysis and electrochemical studies, Brain Res., 518 (1990) 55-60.
38. Morari, M., O'Connor, W.T., Ungerstedt, U. and Fuxe, K., N-Methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA and glutamate levels in the dorsolateral neostriatum of the Halothane-anesthetized rat: an in vivo microdialysis study, J. Neurochem., 60 (1993) 1884-1892.
39. 2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid, Eur. J. Pharmacol., 256 (1993) 23-30.
40. Mount, H., Quirion, R., Kohn-Alexander, J. and Boska, P., Subtypes of excitatory amino acid receptors involved in the stimulation of 3H-dopamine release from cell cultures of rat ventral mesencephalon, Synapse, 5 (1990) 271-280.
41. 3H-dopamine release from dissociated cell cultures of rat ventral mesencephalon, J. Neurochem., 52 (1989) 1300-1310.
42. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
43. 2 Dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors, Neuroscience, 60 (1994) 97-114.
44. Ransom, R.W. and Deschenes, N.L., Glycine modulation of NMDA-evoked release of [3H]acetylcholine and [3H]dopamine from rat striatal slices, Neurosci. Lett., 96 (1989) 323-328.
45. Rao, T.S., Kim, H.S., Lehmann, J., Martin, L.L. and Wood, P.L., Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat, J. Neurochem., 54 (1990) 1157-1162.
46. Roberts, P.J. and Anderson, S.D., Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions, J. Neurochem., 32 (1979) 1539-1545.
47. 3H-dopamine from rat striatal slices, Brain Res., 157 (1978) 391-395.
48. Rosales, M.G., Flores, G., Hernandez, S., Martinez-Fong, D. and Aceves, J., Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat, Brain Res., 645 (1994) 335-337.
49. Vickroy, T.W. and Jonhson, K.M., Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices, J. Pharmacol. Exp. Ther., 223 (1982) 669-674.
50. Waters, N., Svensson, K., Haadsma-Svensson, S.R., Smith, M.W. and Carlsson, A., The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity, J. Neural Transm., 94 (1994) 11-19.
51. 1 receptors, Brain Res., 622 (1993) 325-329.
52. Whitton, P.S., Maione, S., Biggs, C.S. and Fowler, L.J., N-Methyl-D-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo, Brain Res., 635 (1994) 312-316.
53. Youngren, K.D., Daly, D.A. and Moghaddam, B., Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens, J. Pharmacol. Exp. Ther., 264 (1993) 289-293.